Payment of reinspection fee

Guidance for Industry on Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the Federal Food, Drug, and Cosmetic Act

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0776 can be found here:

Documents and Forms

Document Name Document Type
FINAL GUIDANCE FOR USER FEES 8-28-14.doc Other-Guidance
3908 Outsourcing Facilities for Human Drug Compounding Small FDA FORM 3908 USER FEE 8-29-14.pdf Form and Instruction

Information Collection (IC) Details

IC Title:	Payment of reinspection fee	Agency IC Tracking Number:	CDER

Is this a Common Form? No		IC Status: New

Obligation to Respond: Mandatory

CFR Citation:

Information Collection Instruments:

Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Other-Guidance			FINAL GUIDANCE FOR USER FEES 8-28-14.doc		Yes	Yes	Paper Only
Form and Instruction	3908	Outsourcing Facilities for Human Drug Compounding Small Business Establishment Fee Reduction Request	FDA FORM 3908 USER FEE 8-29-14.pdf		Yes	Yes	Fillable Fileable Signable

Line of Business: Health

Subfunction: Health Care Services

Privacy Act System of Records
Title:	FR Citation:

Number of Respondents: 15	Number of Respondents for Small Entity: 0

Affected Public: Private Sector	Private Sector: Businesses or other for-profits

Percentage of Respondents Reporting Electronically: 100 %

	Approved	Program Change Due to Agency Discretion
Annual Number of Responses for this IC	15	15
Annual IC Time Burden (Hours)	8	8
Annual IC Cost Burden (Dollars)	0	0

Documents for IC

Title	Document	Date Uploaded
No associated records found

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.